FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustrationWorld-leading drug companies Sanofi and Glaxo have begun trials of a coronavirus vaccine on humans for the first time.Both firms aim to supply up to one billion vaccine doses in 2021, but new research from the WHO suggests that Covid-19 vaccinations are not expected until mid-2021.
Both firms expect to have results by early December this year and will then look to progress into phase three by the end of this year. If the results are successful, GSK and Sanofi will request regulatory approval in the first half of next year. Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur said in a statement that the beginning of the clinical study is an important step in helping defeat COVID-19.
Meanwhile, Roger Connor, President of GSK Vaccines, described the trials as "an important moment" in addressing the coronavirus pandemic and "builds on the confidence shown by governments."
Its still not to late to invest in Glaxo as all signs point to them getting the bulk of the contract here. Follow me for ongoing details.
Click bait
Possible side-effects: COVID-19
Ireland Ireland Latest News, Ireland Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »